Pages that link to "Q50595888"
Jump to navigation
Jump to search
The following pages link to Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries (Q50595888):
Displaying 50 items.
- Statins for the primary prevention of cardiovascular disease (Q24201513) (← links)
- Statins for the primary prevention of cardiovascular disease (Q24234813) (← links)
- Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis (Q24628361) (← links)
- The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials (Q24646234) (← links)
- Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit (Q24650533) (← links)
- Debate: Are surrogate end-point studies worth the effort? (Q24792553) (← links)
- Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors (Q24803555) (← links)
- Development of Antiatherosclerotic Drugs on the basis of Natural Products Using Cell Model Approach (Q26782745) (← links)
- Angle between the common and internal carotid arteries detected by ultrasound is related to intima-media thickness among those with atherosclerotic disease (Q27343725) (← links)
- Statins in the treatment of chronic heart failure: a systematic review (Q28200294) (← links)
- Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial (Q28236480) (← links)
- Differential impacts of blood pressure and lipid lowering on regression of ventricular and arterial mass: the Stop Atherosclerosis in Native Diabetics Trial (Q30464117) (← links)
- All cholesterol-lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT. (Q31101617) (← links)
- Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. (Q31887210) (← links)
- Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes mellitus (Q31966638) (← links)
- HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data (Q32050110) (← links)
- Statins and total (not LDL) cholesterol concentration and outcome of myocardial infarction: results from a meta-analysis and an observational study (Q33500185) (← links)
- Pravastatin. A pharmacoeconomic review of its use in primary and secondary prevention of coronary heart disease (Q33584131) (← links)
- Clinical positioning of HMG-CoA reductase inhibitors in lipid management protocols (Q33646070) (← links)
- The effect of dyslipidemic drugs on mortality: A meta-analysis (Q33671245) (← links)
- Noninvasive procedures for subclinical atherosclerosis risk assessment (Q33731836) (← links)
- Statins and cerebrovascular disease: plaque attack to prevent brain attack (Q33805146) (← links)
- Cerebral blood flow evaluation of intensive rosuvastatin therapy in stroke/transient ischemic attack patients with intracranial arterial atherosclerotic stenosis study: Rationale and design. (Q33810068) (← links)
- Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke (Q33815841) (← links)
- Stroke prevention: hypertension, diabetes, tobacco, and lipids (Q33886950) (← links)
- Effect of a multimodality natural medicine program on carotid atherosclerosis in older subjects: a pilot trial of Maharishi Vedic Medicine (Q33958589) (← links)
- Effects of Statins on Progression of Coronary Artery Disease as Measured by Intravascular Ultrasound (Q33962454) (← links)
- Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials (Q34065021) (← links)
- Clinically relevant differences between the statins: implications for therapeutic selection (Q34093408) (← links)
- Basic mechanisms of stroke prevention with lipid-lowering therapy (Q34107366) (← links)
- Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials (Q34142678) (← links)
- Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors (Q34207135) (← links)
- HMG-CoA reductase inhibitors (Q34236671) (← links)
- The antiatherogenic effects of antihypertensive treatment: trials completed and ongoing (Q34317671) (← links)
- Primary stroke prevention (Q34339048) (← links)
- Differential effects of the changes of LDL cholesterol and systolic blood pressure on the risk of carotid artery atherosclerosis (Q34383087) (← links)
- Assessment of subclinical atherosclerosis and cardiovascular risk. (Q34397021) (← links)
- Mutation C3256T of mitochondrial genome in white blood cells: novel genetic marker of atherosclerosis and coronary heart disease. (Q34441663) (← links)
- Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial (Q34517714) (← links)
- Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial (Q34571157) (← links)
- Treatment of lipid disorders after stroke (Q34674265) (← links)
- Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis (Q34760603) (← links)
- Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin (Q34773911) (← links)
- Atherothrombotic plaques and the need for imaging (Q35027547) (← links)
- B-mode ultrasound and spiral CT for the assessment of carotid atherosclerosis (Q35027570) (← links)
- Surrogate measures of atherosclerosis and implications for evaluating cardiovascular risk (Q35083561) (← links)
- Statin treatment and progression of atherosclerotic plaque burden (Q35100297) (← links)
- 34th Bethesda Conference: Task force #3--What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? (Q35150522) (← links)
- Management of hyperlipidemia in patients with vascular disease (Q35157129) (← links)
- Noninvasive atherosclerosis imaging for predicting cardiovascular events and assessing therapeutic interventions (Q35602766) (← links)